226 Results (Page 1 of 10)
India Markets Research Reports
India Radiotherapy Market Analysis
By 2030, it is anticipated that the India Radiotherapy Market will reach a value of $250 Mn from $126 Mn in 2022, growing at a CAGR of 9% during 2022-30. The Radiotherapy Therapeutics Market in India is dominated by a few domestic players such as Bhabha Atomic Research Centre (BARC), HCG Group, and Elekta. The radiotherapy market in India is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for India Radiotherapy is increasing on account of the rise in cancer cases in the country.
India Medical and Diagnostic Laboratory Service Market Analysis
This report presents a strategic analysis of the India Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Medical and Diagnostic Laboratory Service Market, offering unmatched value, accuracy and expert insights.
India Cancer Pain Management Market Analysis
India's Cancer Pain Management market is projected to grow from $118.57 Mn in 2022 to $224.39 Mn by 2030, registering a CAGR of 8.3% during the forecast period of 2022 - 2030. The main factors driving the growth would be government initiatives, increasing private sector investment, rising incidence of cancer, and technological advances. The market is segmented by drug type and by disease. Some of the major players include Accord Healthcare (IND), Dr. Reddy’s (IND), Pfizer, Abbott, and Teva Pharmaceuticals.
India In Vitro Fertilisation (IVF) Service Market Analysis
This report presents a strategic analysis of India's In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about India's In Vitro Fertilisation (IVF) Service Market, offering unmatched value, accuracy and expert insights.
India Dermatology Drugs Market Analysis
By 2030, it is anticipated that India's dermatology drugs market will reach a value of $870 Mn from $309 Mn in 2022, growing at a CAGR of 13.8% during 2022-30. The dermatology drug market in India is dominated by a few large pharmaceutical companies such as Vibcare Pharma Zee Laboratories and Sun Pharmaceutical Industries Limited. The dermatology drug market in India is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel. The major factors affecting the Indian dermatology drugs market are the increasing disease burden of non-communicable diseases, the lack of a proper reimbursement process, and the high cost of drugs.
India Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
India's COPD Therapeutics Market was valued at $332 Mn in 2022 and is estimated to expand at a CAGR of 10.1% from 2022 to 2030 and will reach $717 Mn in 2030. One of the main reasons propelling the growth of this market is the increased prevalence rate and government initiative. The market is segmented by Drug class and by distribution channel. Some key players in this market are Cipla, Glenmark Pharmaceuticals, Lupin Limited, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva India Limited and others.
India Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the India Oncology Therapeutics Market will reach a value of $7.8 Bn from $3.3 Bn in 2022, growing at a CAGR of 11.4% during 2022-2030. The Oncology Therapeutics Market in India is dominated by a few domestic pharmaceutical companies such as Cipla, Cadila Medical care, and Dr. Reddy's Research facilities. The Oncology Therapeutics Market in India is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for India Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
India Artificial Intelligence (AI) in Healthcare Market Analysis
India's Artificial Intelligence (AI) in the healthcare market is projected to grow from $0.13 Bn in 2022 to $2.92 Bn by 2030, registering a CAGR of 48.22% during the forecast period of 2022-30. The market will be driven by Increasing healthcare demands due to the rising population, government support, and initiatives. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Qure.ai & PharmEasy.
India Healthcare Insurance Market Analysis
The Indian healthcare insurance market is projected to grow from $36.85 Bn in 2022 to $82.5 Bn by 2030, registering a CAGR of 10.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be growing awareness, technological advancements, increased competition and government Initiatives. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include HDFC ERGO, Star Health and Allied Insurance, Niva Bupa, ICICI Lombard and Care Health Insurance.
India Coronary Stents Market Analysis
India's Coronary Stents Market is expected to grow from $206 Mn in 2022 to $373 Mn in 2030 with a CAGR of 7.75% for the forecasted year 2022-30. The need for coronary stents is being driven by a rising rate of heart disease in India. The prevalence of CAD is rising in India as a result of the rising incidence of risk factors such as diabetes, hypertension, and obesity. The market is segmented by type, by mode of delivery, by materials, and by end user. Some key players in this market include GPC Medical, Becton Dickinson, Sahajanand Medical Technologies, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
India 3D Printing Medical Devices Market Analysis
India's 3D printing medical devices market size was valued at $54 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $222 Mn in 2030. The market is segmented by component, application, technology, and end user. The India 3D Printing Medical Devices market will grow as the 3D printing technology allows for the customization of medical devices, which is becoming increasingly important in the healthcare industry. The key market players are 3D Life Prints, Osteo3d, Ayushman3D, Anatomiz3D Medtech, SLM Solutions, EOS, and others.
India Digital Health Market Analysis
India's digital health market is projected to grow from $3.83 Bn in 2022 to $18.34 Bn by 2030, registering a CAGR of 21.6% during the forecast period of 2022-30. A combination of a large potential market and supportive government policies is expected to drive strong growth in the India digital health market in the coming years. The market is segmented by solution, by deployment, by end-use. Some of the major players include Practo Technologies Pvt. Ltd, Philips Healthcare & Siemens Healthcare Pvt.
India Oncology Drugs Market Analysis
By 2030, it is anticipated that the India oncology drugs market will reach a value of $10.6 Bn from $3.6 Bn in 2022 and is expected to grow at a CAGR of 14.6% during 2022-30. The companies operating in the oncology drug in India market are Roche Diagnostics, Novartis Oncology and Celgene Corporation. This market is segmented on the basis of therapy modality and types of cancer. Factors such as increased awareness about cancer and its treatments, rising disposable incomes, and improved access to healthcare are some of the major drivers of growth in the Indian oncology drug market.
India Clinical Diagnostics Market Analysis
India's clinical diagnostic market was valued at $1.25 Bn in 2022 and is estimated to expand at a CAGR of 9% from 2022-30 and will reach $2.5 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Thyrocare, Suburban Diagnostics, Metropolis Healthcare, SRL Diagnostics, Dr. Lal PathLabs, and others.
India Dialysis Market Analysis
India's dialysis market is projected to grow from $2.113 Bn in 2022 to $4.368 Bn by 2030, registering a CAGR of 9.50% during the forecast period of 2022 to 2030. The incidence of chronic kidney disease in India is on the rise due to factors such as diabetes and hypertension, which are becoming more prevalent in the country. This is driving the demand for dialysis treatment. Fresenius Medical Care is one of the leading players in the market, with a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services.
India Telemedicine Market Analysis
India's telemedicine market was valued at $1.10 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 21.2% from 2022-30 and will reach $5.15 Bn in 2030. One of the main reasons propelling the growth of this market is the advent of advanced technologies and rising cases of chronic and lifestyle-related diseases. The market is segmented by end-user, product type, and Delivery mode. Some key players in this market are Apollo Telehealth Services, Practo Technologies, 1mg Technologies, and Clove Dental.
India Home Healthcare Market Analysis
India's home healthcare market was valued at $179 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.40% from 2022 to 2030 and will reach $295 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, The increased prevalence of chronic ailments. The market is segmented by equipment outlook and by services. Some key players in this market are Apollo Homecare, Portea Medical, India Home Health Care, Healthcare at Home, and Care24.
India Oral Care Market Analysis
India's oral care market was valued at $641 Mn in 2022 and is estimated to expand at a CAGR of 9.2% from 2022 to 2030 and will reach $1295 Mn in 2030. One of the main reasons propelling the growth of this market is Increasing urbanization, and an aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Dabur India, Patanjali Ayurved, Colgate-Palmolive, Himalaya Wellness, Vicco Laboratories, Procter & Gamble, Baidyanath Ayurveda, and Unilever.
India Electronic Records Management Solutions Market Analysis
India's electronic records management solutions market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by solution and deployment. India's electronic records management solutions market is growing as there is an increased need for ERMS solutions due to the expanding usage of digital technologies in the healthcare industry. The key market players are Practo, HealthPlix, MedCords, Biofourmis, Innovaccer, and others.
India Dermatological Therapeutics Market Analysis
India Dermatological Therapeutics Market is at around $0.77 Bn in 2022 and is projected to reach $1.65 Bn in 2030, exhibiting a CAGR of 11.6% during the forecast period. The market is expanding due to factors like improved healthcare infrastructure, increased awareness and demand, and technological advancements. The market is dominated by key players like Gladerma India Private Limited (IND), Dr. Reddy’s Laboratories (IND), Cipla (IND), Sun Pharmaceutical Industries (IND), Lupin (IND), Zydus Cadila (IND), Torrent Pharmaceuticals (IND), Alkem Laboratories (IND), Glenmark Pharmaceuticals (IND), Pfizer, Johnson & Johnson, Novartis AG, and GlaxoSmithKline PLC.
India Cardiovascular Drugs Market Analysis
India Cardiovascular Drug Market is at around $2.52 Bn in 2022 and is projected to reach $4.26 Bn in 2030, exhibiting a CAGR of 6.8% during the forecast period. The main market drivers include changing lifestyles that result in a higher prevalence of cardiovascular illnesses including hypertension. The market is dominated by key players like Cipla (IND), Torrent Pharmaceuticals (IND), Glenmark Pharmaceuticals (IND), Sun Pharmaceutical Industries (IND), Dr. Reddy's Laboratories (IND), Lupin (IND), Aurobindo Pharma (IND), Cadila Healthcare (IND), Wockhardt (IND), and Alembic Pharmaceuticals (IND).
India ePharmacy Market Analysis
This report presents a strategic analysis of the India ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the India ePharmacy Market, offering unmatched value, accuracy, and expert insights.
India Women Health Diagnostic Market Analysis
This report presents a strategic analysis of the India Women's Health Diagnostic Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the India Women's Health Diagnostic Market, offering unmatched value, accuracy, and expert insights.
India Robotic Surgery Services Market Analysis
India's Robotic Surgery Service market size was valued at $78 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 22.3% % from 2022-30 and will reach $390 Mn in 2030. The robotic surgery service market will grow due to the development of new and improved robotic surgical systems is making these procedures more accessible and affordable, and helping to increase awareness about their benefits among healthcare providers and patients. The market is segmented by product and service type, application type, and end user. Some of the major players are Transasia Bio-Medicals Ltd, Medtronic India, Wipro GE Healthcare, Apollo Hospitals Enterprise Ltd, Fortis Healthcare Ltd (IND), and others
India Physiotherapy Market Analysis
India's physiotherapy market size was valued at $0.96 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.85% from 2022 to 2030 and will reach $1.9 Bn in 2030. This market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The key players are BTL Industries. Performance Health, ITO Co., Ltd., Enraf-Nonius B.V., and others.